Fitness trackers: how wearable data can flag pregnancy before a test does

Over the past year, a growing number of wearable users have reported noticing something odd well before a home pregnancy test would: a sudden jump in resting heart rate, a skin temperature that stubbornly refuses to drop overnight, an unexplained shift in sleep patterns. Ravika, one of the women cited by the BBC, is among hundreds who noticed a shift in her device's data days before a missed period — and tested early because of it.
The signal is not coming from a dedicated 'pregnancy detection' feature bolted onto the hardware. It comes from three data sets that brands including Oura, Apple Watch, Fitbit and Garmin have already been collecting for years for cycle tracking: resting heart rate, heart rate variability and basal body temperature. Normally, these measurements are used to predict ovulation and the likely date of a next period.
The physiology behind it is well understood. After fertilisation, progesterone rises rapidly, keeping body temperature elevated beyond the typical 0.3–0.5°C post-ovulation bump — and keeping it elevated past the day a period would normally arrive. Resting heart rate, meanwhile, can climb by several beats per minute in the first eight to ten weeks of pregnancy as blood volume increases, a shift trackers record with precision overnight.
Some manufacturers already surface this pattern to users. Oura's temperature trend graph can highlight an unexpected plateau partway through a cycle; Apple's Health app cycle tracking can flag a similar deviation. No company markets this as an official pregnancy test, but anecdotes along the lines of 'my device told me before the test did' have become common on user forums.
Ravika's experience is not an isolated one. Women trying to conceive, or simply tracking their cycle closely, describe taking their device's prompt seriously enough to test earlier than they otherwise would have. For some, that becomes the first confirmation of a planned pregnancy; for others, it's the first hint of unexpected news.
Experts urge caution. Pregnancy is not the only thing that raises resting heart rate and body temperature — a mild illness, alcohol, a bad night's sleep or stress can produce a similar pattern. No device manufacturer presents this data as a diagnostic tool; instead, users are advised to take a home test or see a doctor if they notice a change.
Still, the quiet accumulation of this data is arguably reshaping awareness of women's health. A decade ago, this kind of physiological insight was largely confined to a small group of women undergoing fertility treatment who tracked basal body temperature by hand each morning. Today, millions of users are gathering the same data passively, in the background.
That shift brings its own privacy debate. Questions about how reproductive health data is stored and who it might be shared with are becoming more pressing, particularly in places where reproductive rights are legally restricted. Women's health advocates say companies should be transparent about how long this data sits on their servers and whether it could be subject to a legal request.
Clinicians, for their part, are cautiously optimistic. Doctors say these patterns can encourage women to test earlier or seek care sooner, which has value for early prenatal planning. But no expert treats wearable data as a substitute for a blood or urine test.
For now, what fitness trackers and rings offer is a hint, not a diagnosis. But as companies begin combining this data at scale with clinically validated algorithms, whether these devices evolve into a genuine early-warning tool is shaping up to be one of the more interesting frontiers in women's health technology.
Read next

Second death reported in New York City legionnaires' disease outbreak
A second person has died in a legionnaires' disease outbreak that has sickened dozens of people in New York City, health officials say, even as they report evidence the source of the bacteria has likely been eliminated.

A common antidepressant may ease long COVID's crushing fatigue, trial finds
A randomized clinical trial of nearly 400 adults found that fluvoxamine, a low-cost, decades-old antidepressant, significantly reduced fatigue and improved quality of life in people with long COVID, making it one of the first medications to show a meaningful benefit for the debilitating symptom.

Mineral sunscreen without the chalky white cast: what UCLA's new formula changes
Mineral sunscreens are prized for being gentler on skin than chemical alternatives, but they have long left users with a visible white cast. Scientists at UCLA say they have redesigned the zinc oxide particles at the heart of the problem, aiming to make mineral sunscreen usable across all skin tones.

Menopause hormone therapy: what it actually treats, and what it doesn't
Menopause hormone therapy has swung from being widely feared to widely recommended, but doctors say expectations have overtaken the evidence. Here is what the treatment reliably helps with, what it doesn't, and how the science has shifted over two decades.

FDA still points to Taylor Farms lettuce in cyclospora outbreak despite a faulty test
US regulators say they remain focused on lettuce supplied by Taylor Farms as the likely source of a multistate cyclospora outbreak, even after one laboratory test used to support that theory turned out to be faulty. Restaurant visits tied to the outbreak have started to decline.